REDOX-regulation of mitochondrial transcription by mitochondrial DNA topoisomerase I
REDOX-regulation of mitochondrial transcription by mitochondrial DNA topoisomerase I
批准号:
273662364
负责人:
Professor Dr. Friedrich Boege
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2017-12-31
中文摘要
线粒体拓扑异构酶I(TOP1MT)是从线粒体DNA(MtDNA)中去除负超螺旋的基因,已被确定为人类线粒体疾病的候选基因。然而,TOP1MT-/-小鼠并没有表现出明显的线粒体功能障碍,尽管mtDNA负性超螺旋显著增加。因此,TOP1MT被认为是mtDNA负超卷曲的调节因子,但该功能在线粒体动态平衡中的作用尚不清楚。我们已经证明TOP1MT是mtDNA转录的直接负调节因子。这一功能可以通过刺激内源性ROS的产生而在分离的线粒体中被抑制。一旦表达了抗氧化的TOP1MT突变体,这种作用就被取消了。我们的观察支持双负循环模型,在该模型中,TOP1MT负调控mtDNA转录,进而受氧化负调控。我们的目标是提供推测的调控环路(目标1)的因果证据,表征所涉及的组件和分子相互作用(目标2),并解决这一机制在氧化应激适应和年龄相关线粒体功能障碍中的作用(目标3)。为此,我们将在分离的线粒体中证明:(I)在TOP1MT耗尽或缺失时,mtDNA转录的氧化还原调制丢失,并且没有被失活或抗氧化的TOP1MT突变体补充;(Ii)线粒体ROS的急剧增加减少了TOP1MT对重链和轻链启动子的招募,减少了TOP1MT的类核结合,增加了负的mtDNA超螺旋,并且这些反应在TOP1MT0/0细胞中得到了野生型TOP1MT的补充,但不能得到失活或抗氧化的TOP1MT突变体的补充。然后,我们将继续通过使上述互补模型受到急性和/或慢性间歇UVA暴露来确定线粒体应激反应中TOP1MT依赖的机制,并监测UVA对ROS水平、mtDNA转录、mtDNA拷贝数、核有丝分裂生物发生、核和mtDNA编码的呼吸复合体的平衡以及呼吸功能的影响。我们最终将通过研究TOP1MT依赖的适应过程在从老年和年轻人类捐赠者的日照和防晒皮肤中分离出来的原代成纤维细胞中的状态来验证TOP1MT依赖的适应过程的生理学相关性。最终,我们的目标是通过在小鼠身上诱导TOP1MT基因敲除来验证我们的结果,但这些实验超出了本应用的范围。我们希望揭示一种提供mtDNA转录局部氧化还原调节的机制。我们期望阐明这一机制是否将呼吸能力调整为线粒体基质中的氧化还原状态,并在有丝分裂-生物发生应激反应中微调有丝分裂-核通讯。我们可能会证实,推测的调控机制的破坏涉及UVA诱导的人皮肤成纤维细胞线粒体功能障碍和与年龄相关的功能障碍。
英文摘要
Mitochondrial topoisomerase I (TOP1MT) removes negative supercoils from mitochondrial DNA (mtDNA) and has been identified as mitochondrial disease candidate gene in humans. However, TOP1MT-/- mice do not exhibit overt mitochondrial dysfunction despite a marked increase in negative mtDNA supercoiling. TOP1MT is thus indicated a regulator of negative mtDNA supercoiling, but the role of that function in mitochondrial homeostasis remains unclear.We have demonstrated that TOP1MT acts as direct negative regulator of mtDNA-transcription. This function can be inhibited in isolated mitochondria by stimulating endogenous ROS production. Upon expression of oxidation-resistant TOP1MT mutants the effect is abolished. Our observations support the model of a double negative loop, in which TOP1MT negatively regulates mtDNA-transcription and is in turn negatively regulated by oxidation. We aim to provide causal proof of the surmised regulatory loop (objective 1), characterise the components and molecular interactions involved (objective 2), and address the role of this mechanism in oxidative stress adaptation and age-associated mitochondrial dysfunction (objective 3). For that pupose, we will demonstrate in isolated mitochondria (i) that REDOX-modulation of mtDNA transcription is lost upon depletion or deletion of TOP1MT and not complemented by inactive or oxidation-resistant TOP1MT mutants, and (ii) that acute increases in mitochondrial ROS diminish the recruitment of TOP1MT to heavy and light strand promoters, decrease nucleoid association of TOP1MT and increase negative mtDNA supercoiling, and that these responses are complemented in TOP1MT0/0 cells by wild type TOP1MT but not inactive or oxidation-resistant TOP1MT mutants. We will then move on to identify TOP1MT-dependent mechanisms in mitochondrial stress responses by subjecting the above complementation models to acute and/or chronic intermittent UVA exposure and monitor the UVA-impact on ROS levels, mtDNA-transcription, mtDNA copy number, nuclear mito-biogenesis, the balance of nuclear and mtDNA-encoded respiratory complexes, and respiratory function. We will finally validate the physiological relevance of TOP1MT-dependent adaptation processes by addressing their state in primary fibroblasts isolated form sun-exposed and sun-protected skin of old and young human donors. Ultimately, we aim at validating our results by inducible TOP1MT knock out in mice, but these experiments are outside the purview of this application.We expect to uncover a mechanism that provides local REDOX-regulation of mtDNA transcription. We expect to elucidate whether this mechanism adjusts respiratory capacity to the REDOX state inside the mitochondrial matrix and serves to fine tune mito-nuclear communication in mito-biogenetic stress responses. We will possibly confirm that disruption of the surmised regulatory mechanism is involved in UVA-induced and age-related mitochondrial dysfunction in human dermal fibroblasts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The foundations of specific radiobiological effects generated by laser-accelerated protons
-
批准号:401832363
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Friedrich Boege
-
依托单位:
Analyse kovalenter DNS-Intermediate von Topoisomerasen und Rekombinasen mittels Antikörper gegen Tyrosin-Nukleinsäure-Phosphodiester
-
批准号:5298546
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Friedrich Boege
-
依托单位:
Topoisomerase I-vermittelter Gentransfer in humane Zellen. Selbständige Entwicklung einer gentherapeutisch anwendbaren Methode zur Patentreife
-
批准号:5244094
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2000
-
负责人:Professor Dr. Friedrich Boege
-
依托单位:
Targeting of DNA-Topoisomerase-II by protein-protein interactions
-
批准号:5179570
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:Professor Dr. Friedrich Boege
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
-
批准号:82371770
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:宁铂涛
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
-
批准号:82371379
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯军峰
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: